Hande Pharma Limited ( China (Mainland))

Hande Pharma Limited, founded in 1999, is a High-Tech enterprise, which is engaged in R&D, production and technical service of new APIs, pharmaceutical intermediates, plant extracts, etc. such as Galanthamine hydrobromide with cas registry number of 1953-04-4, 2-C-Methyl-1,3,5-tri-O-benzoyl-alpha-D-ribofuranoside with cas registry number of 16434-48-3, 1,3,5-Tri-O-benzoyl-D-ribofuranose with cas registry number of 22224-41-5, 1,2,3-Triacetyl-5-deoxy-D-ribose with cas registry number of 62211-93-2, Dess-Martin periodinane with cas registry number of 87413-09-0. The products have been applied or been obtained China and USA invention patents.

Hande also provides technical service, and creat value for customers. Hande is specialized in difficult synthesis development and industrialization. The development and production of Ribose derivates and Carbapenem Series has been at the leading position in China.

Hande owns a professional, united, high effective research and development team. It takes international stardards as the principle. In 2003, Hande R&D center was approved to station with several science and technology departments and Shenzhen high-tech projects in the "Shenzhen High-Tech Industries zone of Biological Incubator", and was awarded Hi-Tech Enterprise on Feb. 12, 2007.

At the same time, Hande has established a long-term cooperation of pharmaceutical information and technological exchange with big pharmaceutical company in Israel. It also has cooperated with Hong Kong and domestic first-class universities, research institutes in technical development, and build up laboratory branches in Beijing and Tianjin.